Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Comtex 5/01/2024, 7:15 AM EDTMonday
U.S.
Economic Lookahead
Tuesday
U.S.
Economic Lookahead
S&P flash U.S. services PMI (April)
S&P flash U.S. manufacturing PMI (April)
Thursday
U.S.
Featured Earnings
Consumer sentiment (April)
Exxon Mobil Corp (NYSE:XOM) (Q1) EPS of $2.12, compared to $2.83 in the prior-year quarter.
Chevron Corp. (NYSE:CVX) (Q1) EPS of $3.03, compared to $3.55 in the prior-year quarter.
AbbVie Inc. (NYSE:ABBV) (Q1) EPS of $2.26, compared to $2.46in the prior-year quarter.
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN19042024000212011056ID1108116858
COMTEX_451118766/2604/2024-04-20T02:59:40
